873056-00-9

Usage

Uses

Used in Pharmaceutical Industry:
(3-nitro-4-propylphenyl)carbamic acid tert-butyl ester is used as an intermediate in the synthesis of pharmaceutical drugs. Its chemical properties and stability make it a valuable component in the development of new medications.
Used in Agrochemical Industry:
(3-nitro-4-propylphenyl)carbamic acid tert-butyl ester is also used as an intermediate in the synthesis of agrochemicals. Its compatibility with other chemicals allows for the creation of effective products for agricultural use.
Safety Precautions:
It is important to handle (3-nitro-4-propylphenyl)carbamic acid tert-butyl ester with caution and use appropriate protective equipment when working with it. This chemical should be stored in tightly sealed containers away from heat, sparks, and open flames to prevent any potential hazards.

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 42411-95-0 4-propyl-3-nitroaniline 
• 24503-35-3 2,4-dinitro-1-propylbenzene 
• 103-65-1 phenylpropane 

Downstream Products

• 873055-95-9 (3-amino-4-propylphenyl)carbamic acid tert-butyl ester 
• 873056-01-0 methyl-(3-nitro-4-propylphenyl)carbamic acid tert-butyl ester 
• 873056-02-1 (3-amino-4-propylphenyl)-methyl-carbamic acid tert-butyl ester 

Relevant academic research and scientific papers

Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases

The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.

MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS

The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.

COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS AND OTHER CHRONIC DISEASES

The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.

PYRAZOLE PYRAZINE AMINE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF AND METHODS OF TREATMENT THEREWITH

Provided herein are Pyrazole Pyrazine Amine Compounds having the following structure:Formula (I). Wherein Q and R1-R3 are as defined herein, compositions comprising an effective amount of a Pyrazole Pyrazine Amine Compound and methods for treating or preventing inflammatory conditions, immunological conditions, cancer, neurodegenerative diseases, age-related diseases, cardiovascular diseases and metabolic conditions, or conditions treatable or preventable by inhibition of an IKK, or an IKK pathway, comprising administering an effective amount of a Pyrazole Pyrazine Amine Compound to a patient in need thereof.